Description
Rebamipide Tablets Product Specifications
| Specification | Description |
|---|---|
| Product Name | Rebamipide Tablets (Rebo / Shenghuaxi) |
| Generic Name | Rebamipide |
| Formulation | Oral tablet |
| Strength | 0.1 g (100 mg) per tablet |
| Pack Size | 12 tablets × 2 blisters (24 tablets total) |
| Approval Number | H20234327 (NMPA, China) |
| Product Code | 86909568000326 |
| Manufacturer | Chongqing Shenghuaxi Pharmaceutical Co., Ltd. |
| Barcode | 6933982500999 |
| Storage Conditions | Store below 30?°C in a dry, dark place |
| Intended Use | For laboratory research use only |
Rebamipide Tablets Mechanism of Action
Rebamipide enhances mucosal defense by increasing prostaglandin synthesis, scavenging free radicals, and promoting mucosal healing. It modulates inflammatory responses and protects against gastric mucosal injury.
Rebamipide Tablets Research Applications & Pharmacology
Experimental studies on gastric mucosal protection
Anti-inflammatory and antioxidative mechanism research
Models of gastric ulcer and mucosal injury
Evaluation of mucosal repair and wound healing
In vitro cell culture assays and in vivo animal models
Safety Profile & Handling
Common preclinical effects are minimal but may include mild gastrointestinal irritation
Use standard laboratory protective equipment (gloves, mask, lab coat)
Avoid inhalation, skin, or eye contact with powder or tablets
Store in a cool, dry place away from direct sunlight and humidity
Dispose of residues according to hazardous waste protocols
Research-Use Disclaimer
This product is intended solely for laboratory research use. It is not approved for clinical, diagnostic, therapeutic, or veterinary use. Improper handling or unauthorized use may pose serious health risks.


Reviews
There are no reviews yet.